The efficacy of PD-L1 blockade on PD-L1 negative medulloblastoma is dependent on timing and the tumor microenvironment

被引：0
|
作者：
Allen, Frederick [1 ,2 ]
Dorand, Rodney Dixon [1 ]
Rauhe, Peter [1 ,2 ]
Petrosiute, Agne [1 ,2 ,3 ]
Huang, Alex Y. [2 ,4 ,5 ]
机构：
[1] Case Western Reserve Univ, Cleveland, OH 44106 USA
[2] Univ Hosp, Dept Pediat, Cleveland, OH USA
[3] Rainbow Babies & Childrens Hosp, Univ Hosp, 2101 Adelbert Rd, Cleveland, OH 44106 USA
[4] Angie Fowler AYA Canc Inst, Cleveland, OH USA
[5] Case Comprehens Canc, Cleveland, OH USA
来源：
JOURNAL OF IMMUNOLOGY | 2018年 / 200卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
178.14
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
    Jiang, Xianjie
    Wang, Jie
    Deng, Xiangying
    Xiong, Fang
    Ge, Junshang
    Xiang, Bo
    Wu, Xu
    Ma, Jian
    Zhou, Ming
    Li, Xiaoling
    Li, Yong
    Li, Guiyuan
    Xiong, Wei
    Guo, Can
    Zeng, Zhaoyang
    MOLECULAR CANCER, 2019, 18 (1)
  • [42] Commensal dysbiosis alters the tumor microenvironment in breast cancer and diminishes efficacy of PD-L1 blockade.
    Rosean, Claire Buchta
    Bostic, Raegan
    Feng, Tzu Yu
    Rutkowski, Melanie R.
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (04) : 68 - 68
  • [43] PD-L1
    Kythreotou, Anthousa
    Siddique, Abdul
    Mauri, Francesco A.
    Bower, Mark
    Pinato, David J.
    JOURNAL OF CLINICAL PATHOLOGY, 2018, 71 (03) : 189 - 194
  • [44] Efficacy of PD-1/PD-L1 immune checkpoint inhibitors and PD-L1 testing in thoracic cancers
    Duruisseaux, Michael
    Rouquette, Isabelle
    Adam, Julien
    Cortot, Alexis
    Cazes, Aurelie
    Gibault, Laure
    Damotte, Diane
    Lantuejoul, Sylvie
    ANNALES DE PATHOLOGIE, 2017, 37 (01) : 61 - 78
  • [45] Soluble PD-L1 levels correlate with efficacy of PD-1/PD-L1 inhibitors in lung cancer
    Kang, Da Hyun
    Koh, Jeong Suk
    Chung, Chaeuk
    Park, Dongil
    Lee, Song-I
    Lee, Jeong Eun
    RESPIROLOGY, 2023, 28 : 99 - 99
  • [46] The efficacy of PD-1/PD-L1 blockade in cold cancers and future perspectives
    Majidpoor, Jamal
    Mortezaee, Keywan
    CLINICAL IMMUNOLOGY, 2021, 226
  • [47] PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment
    Dimitrios Mathios
    Jacob Ruzevick
    Christopher M. Jackson
    Haiying Xu
    Sagar Shah
    Janis M. Taube
    Peter C. Burger
    Edward F. McCarthy
    Alfredo Quinones-Hinojosa
    Drew M. Pardoll
    Michael Lim
    Journal of Neuro-Oncology, 2015, 121 : 251 - 259
  • [48] PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment
    Mathios, Dimitrios
    Ruzevick, Jacob
    Jackson, Christopher M.
    Xu, Haiying
    Shah, Sagar
    Taube, Janis M.
    Burger, Peter C.
    McCarthy, Edward F.
    Quinones-Hinojosa, Alfredo
    Pardoll, Drew M.
    Lim, Michael
    JOURNAL OF NEURO-ONCOLOGY, 2015, 121 (02) : 251 - 259
  • [49] The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy
    Qian, Jiawen
    Wang, Chen
    Wang, Bo
    Yang, Jiao
    Wang, Yuedi
    Luo, Feifei
    Xu, Junying
    Zhao, Chujun
    Liu, Ronghua
    Chu, Yiwei
    JOURNAL OF NEUROINFLAMMATION, 2018, 15
  • [50] PD-L1 blockade enhances anti-tumor efficacy of NK cells
    Oyer, Jeremiah L.
    Gitto, Sarah B.
    Altomare, Deborah A.
    Copik, Alicja J.
    ONCOIMMUNOLOGY, 2018, 7 (11):
12345